Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.

Authors:
Nicola Fleming Lori J Sacks Cecilia T Pham Sandra L Neoh Elif I Ekinci

Diabet Med 2021 03 5;38(3):e14509. Epub 2021 Feb 5.

Department of Medicine Austin Health, Melbourne Medical School, The University of Melbourne, Austin Health, Heidelberg, Vic., Australia.

Introduction: The coronavirus disease (COVID-19) pandemic has continued to have a devastating impact on health worldwide. There has been a rapid evolution of evidence, establishing an increased risk of morbidity and mortality associated with diabetes and concurrent COVID-19. The objective of this review is to explore the current evidence for inpatient assessment and management of diabetes during the COVID-19 pandemic and highlight areas requiring further exploration.

Methods: A literature search of databases was conducted to November 2020 using variations on keywords SARS-CoV-2, COVID-19, SARS, MERS and diabetes. Information relating to the impact of diabetes on severity of COVID-19 infection, the impact of COVID-19 infection on diabetes management and diabetes-related complications was integrated to create a narrative review.

Discussion: People with diabetes and COVID-19 are at an increased risk of morbidity and mortality. It is important that people with both known and previously unrecognised diabetes and COVID-19 be promptly identified and assessed during acute illness, with close monitoring for clinical deterioration or complications. People with diabetes may require titration or alteration of their glycaemic management due to the potential for worse outcomes with hyperglycaemia and COVID-19 infection. Comprehensive discharge planning is vital to optimise ongoing glycaemic management.

Conclusion: Further understanding of the risk of adverse outcomes and optimisation of glycaemic management for people with diabetes during COVID-19 is required to improve outcomes. Increased glucose and ketone monitoring, substitution of insulin for some oral anti-hyperglycaemic medications and careful monitoring for complications of diabetes such as diabetic ketoacidosis should be considered.

Download full-text PDF

 Source
http://dx.doi.org/10.1111/dme.14509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883197PMC
March 2021

Publication Analysis

Top Keywords

people diabetes
16
diabetes covid-19
16
covid-19 infection
12
diabetes
11
covid-19
10
covid-19 pandemic
8
glycaemic management
8
risk morbidity
8
morbidity mortality
8
increased risk
8
people
5
mortality people
4
people unrecognised
4
unrecognised diabetes
4
covid-19 increased
4
reviewdiscussion people
4
integrated create
4
create narrative
4
narrative reviewdiscussion
4
covid-19 identified
4

Keyword Occurance

Similar Publications

Swietenine potentiates the antihyperglycemic and antioxidant activity of Metformin in Streptozotocin induced diabetic rats.

Authors:
Zhang Shiming Kit-Kay Mak Madhu Katyayani Balijepalli Srikumar Chakravarthi Mallikarjuna Rao Pichika

Biomed Pharmacother 2021 Apr 13;139:111576. Epub 2021 Apr 13.

Pharmaceutical Chemistry Department, School of Pharmacy, International Medical University, 126 Jalan Jalil Perkasa 19, Bukit Jalil, 57000 Kuala Lumpur, Malaysia; Centre of Excellence for Bioactive Molecules and Drug Delivery, Institute for Research, Development & Innovation (IRDI), International Medical University, 126 Jalan Jalil Perkasa 19, Bukit Jalil, 57000 Kuala Lumpur, Malaysia. Electronic address:

Diabetes mellitus or type-2 diabetes, commonly referred as diabetes, is a metabolic disorder that results in high blood sugar level. Despite the availability of several antidiabetic drugs in the market, they still do not adequately regulate blood sugar levels. Thus, in general people prefer to use herbal supplements/medicines along with antidiabetic drugs to control blood sugar levels. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The WHO Global Diabetes Compact: a new initiative to support people living with diabetes.

Authors:
Daniel Hunt Bianca Hemmingsen Alena Matzke Cherian Varghese Asmus Hammerich Silvana Luciani Anselm Hennis Francesco Branca Fiona Bull Nino Berdzuli Jean-Marie Dangou Razia Pendse Angela Pratt Bente Mikkelsen

Lancet Diabetes Endocrinol 2021 Apr 13. Epub 2021 Apr 13.

Department for Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.

View Article and Full-Text PDF
April 2021
Similar Publications

New Apps Drive Health Care Innovation, Access to Care.

Authors:
Summer Allen

IEEE Pulse 2021 Mar-Apr;12(2):28-32

With the ubiquitous nature of smartphones, apps are a regular part of our day-to-day lives. They are also becoming a larger presence in health care, where they have the ability to expand access to care, help people monitor health changes, provide support for people living with chronic conditions, and coordinate communication between patients and their doctors. From detecting skin cancer to helping people with diabetes, new apps aim to change how people think about their health. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Metformin for Preventing Type 2 Diabetes Mellitus in Women with a Previous Diagnosis of Gestational Diabetes: A Narrative Review.

Authors:
Vincent L Versace Hannah Beks Hannah Wesley Kevin McNamara William Hague Ranjit Mohan Anjana Viswanathan Mohan Kamlesh Khunti James A Dunbar

Semin Reprod Med 2021 Apr 15. Epub 2021 Apr 15.

School of Medicine, Deakin University, Geelong, Australia.

Women with a history of gestational diabetes mellitus (GDM) are at greater risk of developing type 2 diabetes mellitus (T2DM) when compared with women who have not had GDM. To delay or prevent T2DM, guidelines recommend regular screening in the primary care setting and lifestyle interventions that are largely focused on dietary and physical activity modifications. As the postpartum period can be challenging for women, uptake and engagement in screening and lifestyle interventions have been poor. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Reproducibility of Glucose Fluctuations Induced by Moderate Intensity Cycling Exercise in Persons with Type 1 Diabetes.

Authors:
Gabriel Tafdrup Notkin Peter Lommer Kristensen Ulrik Pedersen-Bjergaard Andreas Kryger Jensen Stig Molsted

J Diabetes Res 2021 30;2021:6640600. Epub 2021 Mar 30.

Department of Clinical Research, Nordsjællands Hospital, Denmark.

Aims: The purpose was to assess the reproducibility of glucose changes during three sessions of standardized moderate intensity continuous training of cycling on an individual level in people with type 1 diabetes.

Methods: Twelve adults (six females) with type 1 diabetes performed three test sessions on an ergometer bicycle (30 min, 67% of predicted heart rate) on three different days. The participants were 36. Read More

View Article and Full-Text PDF
March 2021
Similar Publications